Use of PRN medication in people with intellectual disabilities

Author:

Delafon Vijay,Kiani Reza,Barrett Mary,Vahabzadeh Arshya,Vaidya Hasit,Walker Gordon,Bhaumik Sabyasachi

Abstract

Purpose – The purpose of this paper is to identify psychotropic medication being prescribed for people with intellectual disability “as and when required” (PRN); the indications, frequency of use, rate of poly-pharmacy and contribution of PRN medication towards this. The paper also aimed to identify individual and environmental factors associated with PRN medication prescribing. Design/methodology/approach – Data were collected from nursing and medical records for the 119 service users in the acute assessment and treatment unit and NHS residential care settings managed by specialist intellectual disability services covering Leicester, Leicestershire and Rutland over a month period. Data were analysed using descriptive statistics and logistic regression to calculate adjusted odds ratios for predictor variables. Findings – In total, 72 per cent of the service users were prescribed and 25 per cent were administered PRN medication over the study period. The most common indications for PRN prescribing were aggression and agitation. Lorazepam and chlorpromazine were the most frequently prescribed PRN medications. The rate of poly-pharmacy was 41 and 38 per cent of this was attributable to PRN medication. Male gender and history of challenging behaviour were found to be significant factors associated with PRN medication prescribing. Originality/value – PRN medications are commonly prescribed in people with intellectual disabilities and contribute to poly-pharmacy. Whilst PRN medication continues to remain an effective therapeutic option in situations where environmental and behavioural approaches are proving insufficient, their use should always be in conjunction with effective review mechanisms.

Publisher

Emerald

Subject

Psychiatry and Mental health

Reference29 articles.

1. Aman, M.G. (1984), “Drugs and learning in mentally retarded persons”, in Burrows, G.D. and Werry, J.S. (Eds), Advances in Human Psychopharmacology, JAI Press, Greenwich, CT, pp. 121-63.

2. Bhaumik, S. and Michael, D.M. (2004), “Pharmacotherapy and pharmaco-vigilance in intellectual disability”, Intellectual Disability Psychiatry, Vol. 6, pp. 9-10.

3. Borthwick-Duffy, S.A. (1994), “Prevalence of destructive behaviours”, in Thompson, T. and Gray, D.B. (Eds), Destructive Behaviour in Developmental Disabilities: Diagnosis and Treatment, Sage, Thousand Oaks, CA, pp. 3-23.

4. Branford, D. (1997), “A follow-up study of prescribing for people with intellectual disabilities previously in National Health Service care in Leicestershire, England”, Journal of Intellectual Disability Research, Vol. 41 No. 4, pp. 339-45.

5. Brylewski, J. and Duggan, L. (1999), “Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomised controlled trials”, Journal of Intellectual Disability Research, Vol. 43 No. 5, pp. 360-71.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3